Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract...

Dr Thorsten Oliver Goetze - The University Cancer Center (UCT), Frankfurt...

Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract cancer ( Dr Thorsten Oliver Goetze - The University Cancer Center (UCT), Frankfurt, Germany )

Cemiplimab reduces disease recurrence as adjuvant therapy for cutaneous...

Dr Danny Rischin - Peter MacCallum Cancer Centre, Melbourne, Australia

Cemiplimab reduces disease recurrence as adjuvant therapy for cutaneous squamous cell carcinoma ( Dr Danny Rischin - Peter MacCallum Cancer Centre, Melbourne, Australia )

ASCO 2025: Update on blood-based cancer assays

Dr Marie Wood - UCHealth University of Colorado Hospital, Aurora, USA

ASCO 2025: Update on blood-based cancer assays ( Dr Marie Wood - UCHealth University of Colorado Hospital, Aurora, USA )

Trastuzumab deruxtecan benefit for some advanced gastric cancers

Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan

Trastuzumab deruxtecan benefit for some advanced gastric cancers ( Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan )

HER2-positive breast cancer: Predicting pCR from clinicopathologic variables...

Dr Nadine M Tung - Beth Israel Deaconess Medical Center, Boston, USA

HER2-positive breast cancer: Predicting pCR from clinicopathologic variables and genomic testing ( Dr Nadine M Tung - Beth Israel Deaconess Medical Center, Boston, USA )

Tumor Treating Fields plus chemo shows OS benefit in unresectable pancreatic...

Dr Vincent Picozzi - Virginia Mason Medical Center, Seattle, USA

Tumor Treating Fields plus chemo shows OS benefit in unresectable pancreatic cancer ( Dr Vincent Picozzi - Virginia Mason Medical Center, Seattle, USA )

Abemaciclib potential therapeutic option for Kaposi sarcoma

Dr Ramya Ramaswami - National Cancer Institute, Bethesda, USA

Abemaciclib potential therapeutic option for Kaposi sarcoma ( Dr Ramya Ramaswami - National Cancer Institute, Bethesda, USA )

Ecological evaluation of climate risks for cancer survivors

Dr Joseph Unger - Fred Hutchinson Cancer Center, Seattle, USA

Ecological evaluation of climate risks for cancer survivors ( Dr Joseph Unger - Fred Hutchinson Cancer Center, Seattle, USA )

Perioperative durvalumab and FLOT chemo can reduce risk of recurrence for some...

Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA

Perioperative durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancers ( Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

Nivolumab/ipilimumab followed by BRAF/MEK inhibitors preferred sequence for...

Dr Michael B. Atkins - Georgetown Lombardi Comprehensive Cancer Center...

Nivolumab/ipilimumab followed by BRAF/MEK inhibitors preferred sequence for BRAF-positive advanced melanoma ( Dr Michael B. Atkins - Georgetown Lombardi Comprehensive Cancer Center, Washington, USA )

Making immune check point inhibitors for lung cancer cost-effective in LMICs

Dr Giulia Segafredo and Dr Dario Trapani

Making immune check point inhibitors for lung cancer cost-effective in LMICs ( Dr Giulia Segafredo and Dr Dario Trapani )

Sacituzumab govitecan helps postpone progression in some PD-L1-positive triple...

Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA

Sacituzumab govitecan helps postpone progression in some PD-L1-positive triple-negative breast cancer patients ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer